Genor Biopharma Co., Ltd.

ACTIVE

Floor 1-4, No.3, 1690 Lane, Zhangheng Road, China Pilot Free Trade Zone, 上海市（市辖区）, 上海市, Chinawww.genorbio.comHolding101–250 employeesEstablished: 2007-12-04

Part of genor biopharma (hk) limited

Clinical Trials

1 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2007

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

66.7%

Phase 2

16.7%

Phase 3

16.7%

Trial Status Distribution

Completed

16.7%

Not yet recruiting

4.2%

Recruiting

12.5%

Unknown

66.7%

Clinical Trials

Trials sponsored by this organization (24)

A Phase I, First-in-Human Study of GB268 (PD-1/CTLA-4/VEGF Trispecific Antibody) in Advanced Solid Tumors

Phase 1

Not yet recruiting

interventional

Apr 2025330 participants

A Study of [14C]GB491 in Male Healthy Subjects

Phase 1

Completed

interventional

Sep 20226 participants

A Safety, Tolerability, PK and Preliminary Activity Study of GB263T in Advanced NSCLC and Other Solid Tumor

Phase 1

Recruiting

interventional

May 2022120 participants

A Study of GB491 in Combination With Letrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer

Phase 3

Recruiting

interventional

Jan 2022350 participants

GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer

Phase 3

Completed

interventional

Sep 2021275 participants

A Safety, Tolerability, Pharmacokinetics and Efficacy Study of GB261 in B-Cell NHL and CLL.

Phase 1

Recruiting

interventional

Aug 2021460 participants

A Phase Ib Study of GB491 Plus Letrozole in Patients With Advanced Breast Cancer

Phase 1

Unknown

interventional

Jun 202110 participants

Single Dose Pharmacokinetic Study of GB221 in Comparison With Herceptin ®

Phase 1

Completed

interventional

Nov 201987 participants

Page 1 of 3

Approvals

No approval data available

News

No news articles found

Back to Organizations